HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ying, H. Articles by Parnes, J. R. Search for Related Content PubMed PubMed Citation Articles by Ying, H. Articles by Parnes, J. R.

Regulation of Mouse CD72 Gene Expression During B Lymphocyte Development¹

Han Ying^*, James I. Healy, Christopher C. Goodnow and Jane R. Parnes^2,*

^* Division of Immunology and Rheumatology, Department of Medicine, and Howard Hughes Medical Institute, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305

CD72 is a 45-kDa transmembrane glycoprotein that is predominantly expressed on cells of the B lineage except plasma cells. Previously, we identified the 255-bp minimal mouse CD72 promoter capable of tissue-specific and developmental stage-specific expression. DNase I footprinting analysis of the 255-bp CD72 promoter revealed three protected elements, footprint (FP) I, FP II, and FP III. FP II, which extends from nucleotide -189 to -169 of the mouse CD72 promoter, exhibited both tissue-specific and developmental stage-specific activity that was reflective of the activity of the CD72 gene in vivo. In this report, we show that FP II is specifically recognized by the transcription factor B cell-specific activator protein (BSAP). Mutations eliminating the binding of BSAP in reporter constructs also eliminated the increase of reporter activity in B cells. In addition, cotransfections with reporter constructs plus different amounts of expression plasmids for BSAP showed that CD72 promoter activity was up-regulated by BSAP in plasmacytoma cells and T cells in a dose-dependent manner. Moreover, the expression level of CD72 decreased 10-fold on normal plasma cells. Compared with the presence of BSAP binding in mature B cells, the binding of BSAP was undetectable in those plasma cells. This study strongly suggests that BSAP-FP II interaction plays a critical role in determining the cell-type specificity of the CD72 promoter. The absence of positive factors such as BSAP accounts for at least part of the loss of mouse CD72 expression in plasma cells and thus might be common for the down-regulation of many molecules at the plasma cell stage.

This article has been cited by other articles:

				L. Rui, J. I. Healy, J. Blasioli, and C. C. Goodnow ERK Signaling Is a Molecular Switch Integrating Opposing Inputs from B Cell Receptor and T Cell Cytokines to Control TLR4-Driven Plasma Cell Differentiation J. Immunol., October 15, 2006; 177(8): 5337 - 5346. [Abstract] [Full Text] [PDF]

				R. Goitsuka, H. Mamada, D. Kitamura, M. D. Cooper, and C.-l. H. Chen2 Genomic Structure and Transcriptional Regulation of the Early B Cell Gene chB1 J. Immunol., August 1, 2001; 167(3): 1454 - 1460. [Abstract] [Full Text] [PDF]

				S. Maitra and M. Atchison BSAP Can Repress Enhancer Activity by Targeting PU.1 Function Mol. Cell. Biol., March 15, 2000; 20(6): 1911 - 1922. [Abstract] [Full Text]

				C. R. Kovac, A. Emelyanov, M. Singh, N. Ashouian, and B. K. Birshtein BSAP (Pax5)-Importin alpha 1 (Rch1) Interaction Identifies a Nuclear Localization Sequence J. Biol. Chem., May 26, 2000; 275(22): 16752 - 16757. [Abstract] [Full Text] [PDF]